Multiple Sclerosis
Conference Coverage
DMTs Are Associated With Reduced Stroke Risk in Patients With MS
LOS ANGELES—Among patients with multiple sclerosis (MS), treatment with disease-modifying therapy is associated with a significantly decreased...
Conference Coverage
CMSC looks to increase advocacy efforts to address looming concerns
Two educational sessions on advocacy aim to inform attendees about specific resources and stakeholders involved in challenges to the MS community...
Medical Education Library
Neurology Board Review: Multiple Sclerosis
Conference Coverage
Rehabilitation in MS is hot topic at CMSC 2018
High-quality research into the most effective practices, however, is still sparse.
Conference Coverage
Wide variety of MS topics on tap at CMSC 2018
Annual meeting will tackle stem cells, ethics, new drugs, suicide, and more.
News
FDA Updates
The FDA approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. Aimovig is the first FDA-approved preventive migraine...
Conference Coverage
Ocrelizumab safety update: Encouraging rates of serious infection, malignancy
No new safety signals were seen in the latest update from studies and postmarketing surveillance of MS patients treated with ocrelizumab.
FDA/CDC
FDA expands fingolimod's indications to treat relapsing MS in pediatric patients
Among individuals who have MS, 2%-5% have symptoms onset before age 18.
Conference Coverage
Interferon treatment does not increase stroke risk in MS
Pooled data from 17 trials, as well as postmarketing surveillance data, show no increase in stroke risk with interferon treatment in MS patients...
Conference Coverage
EVOLVE-MS-1 study: ALKS 8700 shows promise for RRMS
LOS ANGELES – ALKS 8700, a novel prodrug of monomethyl fumarate, looks promising as an oral, disease-modifying treatment for RRMS.
Literature Review
Deep Gray Matter Volume Loss May Drive Disability Worsening in MS
Deep gray matter volume loss drives disability accumulation in multiple sclerosis (MS), according to a multicenter, longitudinal study published...